Form 4: Assembly Biosciences Principal Accounting Officer Sells Shares to Cover Tax Obligations

Jeanette M. Bjorkquist, Principal Accounting Officer of Assembly Biosciences, sold shares to cover tax withholding obligations related to the vesting and settlement of restricted stock units.

Summary

• On May 23, 2024, Jeanette M. Bjorkquist, the Principal Accounting Officer of Assembly Biosciences, sold 24 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
• The shares were sold at a weighted average price of $14.9338, with individual transactions ranging from $14.74 to $15.20.
• Following the transaction, Bjorkquist directly owns 3,142 shares of Assembly Biosciences common stock.

Sentiment

Score: 6

Explanation: The transaction is a routine sale to cover tax obligations, which is neutral. The amount of shares sold is small relative to the total shares owned, suggesting no major concern from the insider.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Comparison to Industry Standards

• Sell-to-cover transactions are a standard method for employees of publicly traded companies to manage the tax implications of equity compensation.
• Many companies, including those in the biotechnology sector like Gilead Sciences or Vertex Pharmaceuticals, have similar policies in place to facilitate these transactions.

Stakeholder Impact

• The sale of a small number of shares is unlikely to have a significant impact on shareholders.
• The transaction ensures the reporting person meets their tax obligations related to their compensation.

Key Dates